DOBUTAMINE

DOBUTAMINE was reported 3813 times

DOBUTAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 244 0.6305
1 ANTACID THERAPY 58 0.4462
2 SLEEP DISORDER THERAPY 88 0.4444
3 ANALGESIC THERAPY 90 0.2804
4 PLATELET DISTRIBUTION WIDTH INCREASED 13 0.2549
5 DRUG THERAPY 83 0.2448
6 ANTICOAGULANT THERAPY 55 0.1937
7 CONGENITAL HIATUS HERNIA 44 0.1930
8 MALIGNANT MELANOMA STAGE 0 34 0.1627
9 SPLENIC CANDIDIASIS 3 0.1304
10 BACTEROIDES INFECTION 32 0.1226
11 ENTERITIS NECROTICANS 3 0.0833
12 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 5 0.0649
13 ADRENAL CORTICAL INSUFFICIENCY 2 0.0606
14 BLOOD PHOSPHORUS INCREASED 165 0.0604
15 SEPTIC CARDIOMYOPATHY 3 0.0600
16 VENOUS OXYGEN SATURATION DECREASED 4 0.0563
17 HYPERPHOSPHATAEMIA 118 0.0548
18 NEONATAL PNEUMOTHORAX 3 0.0545
19 POSTHAEMORRHAGIC HYDROCEPHALUS 3 0.0517
20 PULMONARY HAEMATOMA 6 0.0513
21 COMPLICATIONS OF TRANSPLANTED HEART 11 0.0512
22 ACQUIRED METHAEMOGLOBINAEMIA 2 0.0455
23 MYOCARDIAL CALCIFICATION 5 0.0427
24 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 38 0.0410
25 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0408
26 ACID-BASE BALANCE DISORDER MIXED 3 0.0400
27 CARDIAC INDEX DECREASED 4 0.0388
28 PENILE NECROSIS 4 0.0360
29 NEONATAL CARDIAC FAILURE 3 0.0333
30 PULMONARY HAEMORRHAGE NEONATAL 3 0.0326
31 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 3 0.0326
32 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0317
33 BLOOD CORTICOTROPHIN ABNORMAL 3 0.0312
34 CARDIOGENIC SHOCK 432 0.0301
35 LOW CARDIAC OUTPUT SYNDROME 10 0.0299
36 PERICARDIAL DRAINAGE 7 0.0293
37 TOTAL LUNG CAPACITY DECREASED 45 0.0282
38 CITRATE TOXICITY 2 0.0278
39 ATELECTASIS NEONATAL 3 0.0278
40 GAMMA-GLUTAMYLTRANSFERASE 3 0.0275
41 APPENDICITIS 248 0.0265
42 PULMONARY HYPERTENSIVE CRISIS 7 0.0258
43 HYPERSENSITIVITY MYOCARDITIS 3 0.0248
44 BRAIN NATRIURETIC PEPTIDE DECREASED 2 0.0238
45 HEPATO-LENTICULAR DEGENERATION 3 0.0238
46 MEAN ARTERIAL PRESSURE DECREASED 6 0.0237
47 RETINOPATHY OF PREMATURITY 13 0.0235
48 VENTRICULAR FIBRILLATION 248 0.0223
49 DECOMPENSATED HYPOTHYROIDISM 3 0.0222
50 UREAPLASMA INFECTION 9 0.0221
51 IRON DEFICIENCY 95 0.0211
52 BLOOD URIC ACID INCREASED 118 0.0204
53 DISSEMINATED MUCORMYCOSIS 8 0.0203
54 VASOPLEGIA SYNDROME 33 0.0201
55 ENTEROBACTER PNEUMONIA 3 0.0192
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 92 0.0182
57 NEWBORN PERSISTENT PULMONARY HYPERTENSION 5 0.0178
58 CARCINOID CRISIS 4 0.0177
59 PERIPARTUM CARDIOMYOPATHY 3 0.0174
60 DILATATION INTRAHEPATIC DUCT ACQUIRED 5 0.0171
61 HYPOPHOSPHATAEMIA 124 0.0168
62 ACHROMOBACTER INFECTION 2 0.0167
63 MYASTHENIA GRAVIS 134 0.0166
64 EOSINOPHILIC MYOCARDITIS 12 0.0164
65 NEONATAL HYPOTENSION 6 0.0163
66 LUNG OPACITY 43 0.0163
67 MENINGOCOCCAL SEPSIS 3 0.0158
68 AORTIC STENOSIS 55 0.0158
69 PERIVENTRICULAR LEUKOMALACIA 4 0.0141
70 RIGHT VENTRICULAR DILATATION 8 0.0138
71 HEART TRANSPLANT REJECTION 14 0.0135
72 RIGHT-TO-LEFT CARDIAC SHUNT 3 0.0135
73 CARDIAC ASTHMA 2 0.0133
74 MULTIPLE ORGAN DYSFUNCTION SYNDROME 378 0.0133
75 MYOCARDIAL RUPTURE 4 0.0131
76 EPIDERMOLYSIS 6 0.0130
77 HEPATIC ISCHAEMIA 4 0.0129
78 CARDIAC OUTPUT DECREASED 11 0.0125
79 HYPOPERFUSION 13 0.0124
80 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 6 0.0123
81 CATHETER SITE WARMTH 2 0.0123
82 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 13 0.0122
83 BLOOD LUTEINISING HORMONE INCREASED 3 0.0122
84 FUNGAL SEPSIS 10 0.0120
85 SPINAL EPIDURAL HAEMATOMA 7 0.0119
86 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0117
87 CARDIOVASCULAR INSUFFICIENCY 19 0.0117
88 PLEURITIC PAIN 32 0.0116
89 RHINOCEREBRAL MUCORMYCOSIS 4 0.0115
90 EDENTULOUS 2 0.0113
91 DRY GANGRENE 7 0.0110
92 PLATELET DYSFUNCTION 3 0.0108
93 VENTILATION PERFUSION MISMATCH 3 0.0107
94 STRESS CARDIOMYOPATHY 61 0.0105
95 PULMONARY ARTERIAL PRESSURE ABNORMAL 3 0.0104
96 ASPIRATION JOINT 2 0.0101
97 NECROTISING OESOPHAGITIS 5 0.0100
98 PULMONARY VENO-OCCLUSIVE DISEASE 7 0.0100
99 RIGHT VENTRICULAR FAILURE 70 0.0100
100 RIGHT VENTRICULAR DYSFUNCTION 11 0.0100
101 ENTEROBACTER BACTERAEMIA 3 0.0099
102 NECROTISING ENTEROCOLITIS NEONATAL 4 0.0099
103 VENTRICULAR FAILURE 3 0.0096
104 CEREBRAL HAEMORRHAGE NEONATAL 2 0.0094
105 HYPERMAGNESAEMIA 6 0.0092
106 ASCITES 269 0.0091
107 SPINAL CORD INFARCTION 4 0.0091
108 MYOCARDIAL INJURY 10 0.0089
109 TROPONIN INCREASED 67 0.0088
110 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 3 0.0086
111 RESPIRATORY SYMPTOM 24 0.0084
112 CARDIAC VALVE REPLACEMENT COMPLICATION 2 0.0082
113 LEFT VENTRICULAR DILATATION 4 0.0078
114 HAEMODYNAMIC INSTABILITY 59 0.0077
115 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 3 0.0077
116 ANISOCYTOSIS 5 0.0076
117 PULMONARY MUCORMYCOSIS 4 0.0076
118 SPINAL CORD HAEMORRHAGE 3 0.0075
119 ATRIAL ENLARGEMENT 2 0.0074
120 ISCHAEMIC HEPATITIS 10 0.0073
121 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 125 0.0073
122 PULMONARY CALCIFICATION 3 0.0073
123 RHONCHI 10 0.0072
124 PROPOFOL INFUSION SYNDROME 5 0.0071
125 BACTERIAL INFECTION 129 0.0069
126 BENIGN PROSTATIC HYPERPLASIA 35 0.0068
127 CATHETER MANAGEMENT 6 0.0067
128 HEART TRANSPLANT 6 0.0066
129 CARDIAC PROCEDURE COMPLICATION 4 0.0066
130 BRASH SYNDROME 9 0.0064
131 BREATH SOUNDS ABNORMAL 31 0.0063
132 BLOOD CALCIUM INCREASED 55 0.0063
133 VENTRICULAR HYPOKINESIA 20 0.0062
134 RALES 36 0.0062
135 STEROID DIABETES 9 0.0060
136 ARRHYTHMIC STORM 2 0.0060
137 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
138 HEPARIN-INDUCED THROMBOCYTOPENIA 29 0.0059
139 CORONARY ARTERY DISSECTION 5 0.0058
140 MUCORMYCOSIS 15 0.0058
141 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0057
142 CYTOMEGALOVIRUS HEPATITIS 2 0.0056
143 PERIPHERAL ISCHAEMIA 23 0.0056
144 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
145 PROTEUS INFECTION 4 0.0056
146 CARDIAC TAMPONADE 26 0.0055
147 DIABETES INSIPIDUS 13 0.0054
148 VENTRICULAR DYSFUNCTION 14 0.0054
149 INTRAVASCULAR HAEMOLYSIS 3 0.0054
150 HYPERLIPIDAEMIA 64 0.0054
151 HEART SOUNDS ABNORMAL 4 0.0053
152 ALKALOSIS 2 0.0052
153 CARDIORENAL SYNDROME 3 0.0052
154 COR PULMONALE 5 0.0052
155 NEURALGIA 127 0.0052
156 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 2 0.0052
157 VENTRICULAR ARRHYTHMIA 19 0.0052
158 EXTREMITY NECROSIS 9 0.0052
159 GRAFT COMPLICATION 3 0.0051
160 CARDIAC FAILURE ACUTE 34 0.0051
161 RESPIRATORY TRACT HAEMORRHAGE 3 0.0050
162 TOXIC EPIDERMAL NECROLYSIS 73 0.0048
163 CEREBRAL HAEMATOMA 16 0.0048
164 BLOOD LACTIC ACID INCREASED 25 0.0047
165 NECROTISING COLITIS 6 0.0047
166 HYPONATRAEMIA 264 0.0047
167 PANCREATIC MASS 5 0.0047
168 HEPATIC HAEMORRHAGE 4 0.0047
169 PLATELET TRANSFUSION 6 0.0047
170 APGAR SCORE LOW 6 0.0047
171 CARDIAC VENTRICULAR THROMBOSIS 6 0.0046
172 NODAL ARRHYTHMIA 4 0.0046
173 VENTRICULAR TACHYCARDIA 74 0.0045
174 HYPERLACTACIDAEMIA 12 0.0045
175 CONGESTIVE HEPATOPATHY 2 0.0045
176 STENOTROPHOMONAS INFECTION 6 0.0044
177 MARROW HYPERPLASIA 3 0.0044
178 ULCER 69 0.0043
179 PULMONARY ARTERIAL PRESSURE INCREASED 7 0.0043
180 HAEMORRHAGIC CEREBRAL INFARCTION 3 0.0043
181 END STAGE RENAL DISEASE 78 0.0043
182 SYMPTOM MASKED 3 0.0041
183 ASPIRATION 45 0.0041
184 NODAL RHYTHM 6 0.0041
185 CEREBRAL VASOCONSTRICTION 3 0.0041
186 SERRATIA INFECTION 3 0.0040
187 BRADYCARDIA NEONATAL 5 0.0040
188 DILATED CARDIOMYOPATHY 4 0.0040
189 GOUT 71 0.0040
190 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 13 0.0039
191 BRAIN NATRIURETIC PEPTIDE INCREASED 12 0.0039
192 ATRIAL THROMBOSIS 8 0.0039
193 MONOCYTE COUNT INCREASED 14 0.0039
194 BLOOD TEST ABNORMAL 54 0.0038
195 FUNGAEMIA 6 0.0038
196 SYSTOLIC DYSFUNCTION 4 0.0038
197 ENTEROCOCCAL BACTERAEMIA 4 0.0038
198 LEFT VENTRICULAR FAILURE 13 0.0038
199 CARDIAC FAILURE CHRONIC 16 0.0038
200 ACUTE PULMONARY OEDEMA 21 0.0037
201 ANION GAP INCREASED 5 0.0037
202 BRONCHOPULMONARY DYSPLASIA 3 0.0037
203 VASCULAR ACCESS COMPLICATION 3 0.0037
204 TOXOPLASMOSIS 4 0.0037
205 OLIGURIA 23 0.0037
206 SEPSIS NEONATAL 3 0.0037
207 TORSADE DE POINTES 29 0.0037
208 ACINETOBACTER INFECTION 4 0.0037
209 NEONATAL HYPOXIA 3 0.0036
210 BEZOAR 5 0.0036
211 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
212 CATHETER SITE HAEMORRHAGE 9 0.0036
213 BRAIN DEATH 11 0.0036
214 DISTRIBUTIVE SHOCK 8 0.0035
215 EJECTION FRACTION 2 0.0034
216 ISCHAEMIC CEREBRAL INFARCTION 4 0.0034
217 VASCULAR STENT THROMBOSIS 7 0.0034
218 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
219 VASOCONSTRICTION 3 0.0034
220 ACUTE LUNG INJURY 4 0.0034
221 ANURIA 29 0.0034
222 RIGHT VENTRICULAR HYPERTROPHY 3 0.0033
223 RESPIRATORY ACIDOSIS 13 0.0033
224 BUNDLE BRANCH BLOCK LEFT 14 0.0033
225 MYOCLONIC EPILEPSY 5 0.0033
226 SHOCK 75 0.0033
227 HAEMOCHROMATOSIS 3 0.0032
228 STAPHYLOCOCCAL SEPSIS 16 0.0032
229 BRAIN STEM HAEMORRHAGE 3 0.0032
230 HEPATIC CONGESTION 3 0.0032
231 HYPERAESTHESIA TEETH 4 0.0032
232 PULMONARY HYPERTENSION 66 0.0032
233 INHIBITORY DRUG INTERACTION 5 0.0032
234 TROPONIN T INCREASED 4 0.0032
235 MICTURITION URGENCY 36 0.0031
236 SEPSIS 351 0.0031
237 INTUSSUSCEPTION 3 0.0031
238 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
239 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
240 STATUS EPILEPTICUS 35 0.0031
241 PULMONARY ALVEOLAR HAEMORRHAGE 17 0.0030
242 METHAEMOGLOBINAEMIA 7 0.0030
243 ENTEROBACTER INFECTION 5 0.0030
244 HYPOGONADISM 3 0.0030
245 BRONCHIECTASIS 20 0.0030
246 ISCHAEMIC CARDIOMYOPATHY 9 0.0029
247 LONG QT SYNDROME 7 0.0029
248 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
249 HYPERCHOLESTEROLAEMIA 28 0.0029
250 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
251 PERITONEAL HAEMORRHAGE 4 0.0029
252 DISSEMINATED INTRAVASCULAR COAGULATION 40 0.0028
253 TUMOUR NECROSIS 3 0.0028
254 MULTI-ORGAN FAILURE 49 0.0028
255 VASCULAR CALCIFICATION 3 0.0028
256 PULMONARY HAEMORRHAGE 22 0.0028
257 HYPERPARATHYROIDISM SECONDARY 7 0.0028
258 SYSTEMIC CANDIDA 7 0.0028
259 CARDIOMYOPATHY 41 0.0028
260 BLOOD CHOLESTEROL INCREASED 129 0.0028
261 CONCOMITANT DISEASE AGGRAVATED 17 0.0028
262 GASTROINTESTINAL NECROSIS 8 0.0027
263 CONDUCTION DISORDER 5 0.0027
264 INTESTINAL ISCHAEMIA 15 0.0027
265 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
266 HEPATITIS FULMINANT 8 0.0027
267 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
268 FULL BLOOD COUNT ABNORMAL 28 0.0026
269 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
270 GENERAL PHYSICAL HEALTH DETERIORATION 304 0.0026
271 ELECTROCARDIOGRAM PR PROLONGATION 2 0.0026
272 CYTOMEGALOVIRUS COLITIS 6 0.0026
273 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
274 HYPOREFLEXIA 5 0.0026
275 ASPIRATION PLEURAL CAVITY 2 0.0026
276 MYOCLONUS 31 0.0026
277 NEUROLOGICAL DECOMPENSATION 6 0.0026
278 SEPTIC SHOCK 112 0.0026
279 KLEBSIELLA INFECTION 13 0.0026
280 HYPORESPONSIVE TO STIMULI 3 0.0026
281 ABDOMINAL DISTENSION 266 0.0025
282 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
283 BLOOD FIBRINOGEN INCREASED 2 0.0025
284 NEONATAL DISORDER 4 0.0025
285 METABOLIC ALKALOSIS 4 0.0025
286 BLEEDING TIME PROLONGED 3 0.0025
287 IMMUNE-MEDIATED MYOCARDITIS 4 0.0025
288 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
289 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
290 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 127 0.0024
291 AKINESIA 5 0.0024
292 HAEMOTHORAX 7 0.0024
293 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 3 0.0024
294 STRIDOR 7 0.0024
295 ADRENAL SUPPRESSION 2 0.0024
296 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
297 CARDIOPULMONARY FAILURE 9 0.0023
298 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
299 ABDOMINAL SEPSIS 2 0.0023
300 RETROPERITONEAL HAEMATOMA 5 0.0023
301 HYPERVOLAEMIA 11 0.0022
302 BLOOD MAGNESIUM INCREASED 2 0.0022
303 DEVICE ALARM ISSUE 4 0.0022
304 PULMONARY CONGESTION 29 0.0022
305 HYPOXIA 77 0.0022
306 PNEUMONIA KLEBSIELLA 4 0.0022
307 PNEUMOPERITONEUM 4 0.0022
308 THROMBOSIS IN DEVICE 7 0.0021
309 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 7 0.0021
310 SPUTUM DISCOLOURED 20 0.0021
311 METABOLIC ACIDOSIS 67 0.0021
312 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
313 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
314 PHARYNGEAL DISORDER 6 0.0021
315 DISCOLOURED VOMIT 2 0.0021
316 PULMONARY VALVE INCOMPETENCE 3 0.0021
317 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
318 CONCOMITANT DISEASE PROGRESSION 4 0.0020
319 VENTRICULAR EXTRASYSTOLES 21 0.0020
320 CARDIOTOXICITY 18 0.0020
321 HYPERNATRAEMIA 10 0.0020
322 HYPERAMMONAEMIA 10 0.0020
323 TRANSAMINASES INCREASED 44 0.0020
324 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
325 LUNG TRANSPLANT 7 0.0020
326 ISCHAEMIA 9 0.0020
327 CHEST X-RAY ABNORMAL 6 0.0020
328 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 10 0.0019
329 MEAN CELL VOLUME DECREASED 3 0.0019
330 CIRCULATORY COLLAPSE 33 0.0019
331 HYPOTONIA NEONATAL 3 0.0019
332 MYOCARDITIS 22 0.0019
333 LIVER FUNCTION TEST INCREASED 41 0.0019
334 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
335 ATRIAL TACHYCARDIA 4 0.0019
336 FOETAL DISTRESS SYNDROME 4 0.0019
337 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
338 CARDIAC DYSFUNCTION 7 0.0019
339 CARDIAC FAILURE 149 0.0019
340 DRY MOUTH 150 0.0018
341 RESPIRATORY ALKALOSIS 3 0.0018
342 SHOCK HAEMORRHAGIC 15 0.0018
343 NOSOCOMIAL INFECTION 4 0.0018
344 EJECTION FRACTION DECREASED 28 0.0018
345 TROPONIN I INCREASED 3 0.0018
346 NECROSIS 10 0.0018
347 CARDIAC HYPERTROPHY 2 0.0018
348 POISONING DELIBERATE 17 0.0018
349 MITRAL VALVE INCOMPETENCE 20 0.0018
350 TRICUSPID VALVE INCOMPETENCE 14 0.0018
351 LOW BIRTH WEIGHT BABY 14 0.0018
352 KOUNIS SYNDROME 4 0.0018
353 EXPOSURE VIA BREAST MILK 7 0.0018
354 HAEMOPTYSIS 49 0.0018
355 THROMBOSIS 141 0.0018
356 CORTISOL DECREASED 2 0.0017
357 CEREBRAL VENTRICLE DILATATION 2 0.0017
358 DIABETES MELLITUS 132 0.0017
359 SPONDYLOLISTHESIS 3 0.0017
360 BILIRUBIN CONJUGATED INCREASED 4 0.0017
361 TUMOUR LYSIS SYNDROME 15 0.0017
362 GASTROINTESTINAL OEDEMA 3 0.0017
363 JUGULAR VEIN THROMBOSIS 3 0.0017
364 GASTROINTESTINAL PERFORATION 7 0.0017
365 HYPOVOLAEMIC SHOCK 8 0.0017
366 HYPERCAPNIA 5 0.0017
367 PULMONARY EMBOLISM 157 0.0017
368 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
369 SLEEP DISORDER 116 0.0016
370 JOINT INJURY 35 0.0016
371 CALCIPHYLAXIS 3 0.0016
372 TRANSPLANT FAILURE 4 0.0016
373 PUPILLARY REFLEX IMPAIRED 3 0.0016
374 STENOSIS 3 0.0016
375 PLEURAL EFFUSION 97 0.0016
376 HEPATIC NECROSIS 6 0.0016
377 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
378 BLOOD CREATINE INCREASED 7 0.0016
379 PULMONARY OEDEMA 70 0.0016
380 COAGULOPATHY 26 0.0016
381 HEPATOSPLENOMEGALY 4 0.0016
382 HAEMOLYSIS 12 0.0016
383 INTENTIONAL PRODUCT MISUSE 136 0.0016
384 ATRIOVENTRICULAR BLOCK 12 0.0016
385 CORONARY ARTERY DISEASE 47 0.0016
386 ARTERIAL THROMBOSIS 3 0.0016
387 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
388 BACTERIAL SEPSIS 5 0.0015
389 PROCEDURAL HAEMORRHAGE 6 0.0015
390 ASPERGILLOSIS 2 0.0015
391 BICYTOPENIA 3 0.0015
392 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
393 CARDIAC ARREST 126 0.0015
394 RESPIRATORY FAILURE 111 0.0015
395 NEPHROGENIC ANAEMIA 7 0.0015
396 URINE OUTPUT DECREASED 13 0.0015
397 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 81 0.0015
398 BLOOD CREATININE INCREASED 96 0.0015
399 CHOLESTASIS 28 0.0015
400 LACTIC ACIDOSIS 47 0.0014
401 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
402 INSULIN RESISTANCE 3 0.0014
403 LIVEDO RETICULARIS 3 0.0014
404 RENAL TUBULAR NECROSIS 14 0.0014
405 DRUG INTOLERANCE 137 0.0014
406 PULMONARY MASS 21 0.0014
407 SINUS TACHYCARDIA 20 0.0014
408 HAEMORRHAGIC DIATHESIS 5 0.0014
409 CEREBELLAR HAEMORRHAGE 2 0.0014
410 SWELLING 131 0.0014
411 LUNG CANCER METASTATIC 4 0.0014
412 PARAPLEGIA 4 0.0014
413 HYPOTHERMIA 14 0.0014
414 BRADYCARDIA 73 0.0014
415 BLOOD UREA INCREASED 23 0.0014
416 GENERALISED OEDEMA 17 0.0014
417 TRANSPLANT REJECTION 11 0.0014
418 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
419 DIABETIC NEPHROPATHY 3 0.0014
420 HEPATIC FAILURE 41 0.0014
421 CYTOMEGALOVIRUS INFECTION REACTIVATION 6 0.0014
422 PSEUDOMEMBRANOUS COLITIS 3 0.0013
423 BRAIN HERNIATION 4 0.0013
424 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
425 ACUTE HEPATIC FAILURE 18 0.0013
426 HYPERKALAEMIA 46 0.0013
427 BLOOD PRESSURE IMMEASURABLE 2 0.0013
428 INTRACARDIAC THROMBUS 4 0.0013
429 IRON DEFICIENCY ANAEMIA 12 0.0013
430 ACUTE RESPIRATORY FAILURE 25 0.0013
431 THERAPY NON-RESPONDER 58 0.0013
432 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
433 BACTERAEMIA 15 0.0013
434 ORTHOPNOEA 4 0.0013
435 OXYGEN CONSUMPTION INCREASED 3 0.0013
436 ATRIAL FLUTTER 10 0.0013
437 ARTERIOSPASM CORONARY 5 0.0012
438 ATELECTASIS 12 0.0012
439 CARDIOMEGALY 15 0.0012
440 RETROPERITONEAL HAEMORRHAGE 3 0.0012
441 PERICARDIAL EFFUSION 28 0.0012
442 ORGANISING PNEUMONIA 6 0.0012
443 ACUTE CORONARY SYNDROME 10 0.0012
444 CONGESTIVE CARDIOMYOPATHY 5 0.0012
445 PULMONARY FIBROSIS 23 0.0012
446 PNEUMONIA BACTERIAL 11 0.0012
447 CARDIO-RESPIRATORY ARREST 50 0.0012
448 CORONARY ARTERY STENOSIS 6 0.0012
449 HYPOTENSION 238 0.0012
450 CARDIOVASCULAR DISORDER 30 0.0012
451 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
452 COMA 56 0.0012
453 AORTIC VALVE INCOMPETENCE 5 0.0012
454 PSEUDOMONAS INFECTION 10 0.0012
455 HEPATIC FIBROSIS 4 0.0012
456 PERIPHERAL VASCULAR DISORDER 6 0.0012
457 CHOREA 2 0.0012
458 PNEUMONIA ASPIRATION 29 0.0012
459 NEPHROPATHY TOXIC 13 0.0012
460 CONDITION AGGRAVATED 351 0.0012
461 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
462 CONSTIPATION 250 0.0011
463 NECROTISING FASCIITIS 4 0.0011
464 BRAIN OEDEMA 14 0.0011
465 DECUBITUS ULCER 9 0.0011
466 SUBDURAL HAEMORRHAGE 3 0.0011
467 IMMUNE THROMBOCYTOPENIA 5 0.0011
468 ABDOMINAL PAIN 254 0.0011
469 PREMATURE DELIVERY 17 0.0011
470 ELECTROCARDIOGRAM QT PROLONGED 38 0.0011
471 ACUTE MYOCARDIAL INFARCTION 31 0.0011
472 DUODENAL ULCER HAEMORRHAGE 3 0.0010
473 ACIDOSIS 8 0.0010
474 ESCHERICHIA SEPSIS 3 0.0010
475 SINUS BRADYCARDIA 10 0.0010
476 HYPOALBUMINAEMIA 8 0.0010
477 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
478 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
479 RESPIRATORY DISTRESS 28 0.0010
480 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
481 ANAEMIA 193 0.0010
482 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
483 CELL DEATH 2 0.0010
484 CREPITATIONS 3 0.0010
485 CEREBRAL ATROPHY 4 0.0010
486 TYPE 1 DIABETES MELLITUS 6 0.0010
487 HIV INFECTION 3 0.0010
488 CYSTITIS HAEMORRHAGIC 4 0.0010
489 CORONARY ARTERY THROMBOSIS 2 0.0010
490 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
491 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
492 PATHOGEN RESISTANCE 9 0.0010
493 ACUTE KIDNEY INJURY 151 0.0010
494 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
495 RESPIRATORY DEPRESSION 12 0.0010
496 POLYURIA 8 0.0010
497 PORTAL HYPERTENSION 3 0.0010
498 DERMATITIS BULLOUS 7 0.0010
499 RENAL FAILURE 128 0.0010
500 PREMATURE BABY 29 0.0010
501 HAEMODIALYSIS 8 0.0010
502 DILATATION VENTRICULAR 2 0.0010
503 INTENTIONAL OVERDOSE 61 0.0010
504 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
505 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
506 HEPATIC CYTOLYSIS 12 0.0009
507 RENAL IMPAIRMENT 79 0.0009
508 HAEMORRHAGE INTRACRANIAL 14 0.0009
509 CATHETER SITE ERYTHEMA 2 0.0009
510 DEREALISATION 2 0.0009
511 MYOPATHY 8 0.0009
512 CLOSTRIDIUM TEST POSITIVE 2 0.0009
513 LUNG INFILTRATION 8 0.0009
514 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
515 CYTOMEGALOVIRUS INFECTION 15 0.0009
516 CHOLESTATIC LIVER INJURY 2 0.0009
517 ENCEPHALOPATHY 22 0.0009
518 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
519 CHRONIC GASTRITIS 2 0.0009
520 BLOOD LOSS ANAEMIA 2 0.0009
521 PNEUMOTHORAX 14 0.0009
522 RENAL INJURY 26 0.0009
523 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
524 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
525 SOMNOLENCE 173 0.0009
526 CAROTID ARTERY STENOSIS 3 0.0009
527 NEUROTOXICITY 15 0.0009
528 C-REACTIVE PROTEIN INCREASED 31 0.0009
529 PULMONARY TOXICITY 6 0.0008
530 DEVICE RELATED INFECTION 13 0.0008
531 BLOOD PRESSURE DECREASED 56 0.0008
532 PROTHROMBIN TIME PROLONGED 5 0.0008
533 HYPERTHYROIDISM 12 0.0008
534 FLUID OVERLOAD 12 0.0008
535 THROMBOTIC MICROANGIOPATHY 8 0.0008
536 CHOLANGITIS 5 0.0008
537 MALNUTRITION 9 0.0008
538 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
539 CATHETER SITE INFECTION 3 0.0008
540 MYOCARDIAL ISCHAEMIA 9 0.0008
541 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
542 RENAL FAILURE CHRONIC 6 0.0008
543 ENDOCARDITIS 4 0.0008
544 OEDEMA PERIPHERAL 95 0.0008
545 CEREBRAL ISCHAEMIA 4 0.0008
546 POST PROCEDURAL HAEMORRHAGE 9 0.0008
547 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
548 HYPERBILIRUBINAEMIA 8 0.0008
549 CATHETER SITE PAIN 2 0.0008
550 PERIORBITAL OEDEMA 4 0.0008
551 PATENT DUCTUS ARTERIOSUS 3 0.0008
552 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
553 AREFLEXIA 2 0.0007
554 LIVER DISORDER 33 0.0007
555 ADRENAL INSUFFICIENCY 9 0.0007
556 WRONG PRODUCT ADMINISTERED 5 0.0007
557 NORMAL NEWBORN 4 0.0007
558 TOXICITY TO VARIOUS AGENTS 124 0.0007
559 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
560 PERIPHERAL VENOUS DISEASE 3 0.0007
561 ABNORMAL LOSS OF WEIGHT 5 0.0007
562 THROMBOCYTOPENIA 82 0.0007
563 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
564 CLONUS 2 0.0007
565 PRODUCT USE IN UNAPPROVED INDICATION 181 0.0007
566 EXTRAVASATION 3 0.0007
567 DRUG LEVEL INCREASED 12 0.0007
568 EXTRASYSTOLES 5 0.0007
569 CANDIDA INFECTION 12 0.0007
570 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
571 DUODENAL ULCER 5 0.0007
572 ATRIAL FIBRILLATION 69 0.0007
573 FEAR 19 0.0007
574 PURULENT DISCHARGE 3 0.0007
575 CORONARY ARTERY BYPASS 4 0.0007
576 HYPOKINESIA 10 0.0007
577 BILIARY COLIC 2 0.0007
578 CAESAREAN SECTION 8 0.0007
579 PRODUCT LABEL CONFUSION 4 0.0007
580 ANHEDONIA 18 0.0007
581 MENTAL STATUS CHANGES 19 0.0007
582 HYPOVOLAEMIA 4 0.0007
583 DRUG ERUPTION 12 0.0007
584 CARDIAC FAILURE CONGESTIVE 54 0.0007
585 BLOOD CULTURE POSITIVE 2 0.0007
586 TACHYPNOEA 9 0.0007
587 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
588 OXYGEN SATURATION DECREASED 37 0.0007
589 CORONARY ARTERY OCCLUSION 9 0.0007
590 HAEMATOCRIT DECREASED 13 0.0007
591 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
592 TACHYCARDIA 58 0.0007
593 SUICIDE ATTEMPT 39 0.0006
594 OFF LABEL USE 563 0.0006
595 NEPHROPATHY 6 0.0006
596 NERVOUS SYSTEM DISORDER 20 0.0006
597 BLOOD CREATININE DECREASED 2 0.0006
598 PRE-ECLAMPSIA 3 0.0006
599 PULSE ABSENT 3 0.0006
600 HEPATOTOXICITY 14 0.0006
601 SUBDURAL HAEMATOMA 9 0.0006
602 MUSCULOSKELETAL STIFFNESS 55 0.0006
603 EOSINOPHILIA 11 0.0006
604 DRUG RESISTANCE 16 0.0006
605 ENTEROCOCCAL INFECTION 3 0.0006
606 LEUKOPENIA 31 0.0006
607 DRUG INTERACTION 98 0.0006
608 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
609 HEPATITIS ACUTE 4 0.0006
610 RENAL FAILURE ACUTE 26 0.0006
611 LIVER INJURY 15 0.0006
612 THERAPY CHANGE 6 0.0006
613 OEDEMA 33 0.0006
614 DRUG INEFFECTIVE 800 0.0006
615 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
616 CORONAVIRUS INFECTION 4 0.0006
617 VOMITING 284 0.0006
618 HYPERGLYCAEMIA 22 0.0006
619 HEPATIC ENZYME ABNORMAL 3 0.0006
620 HEPATIC FUNCTION ABNORMAL 22 0.0006
621 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
622 RESPIRATION ABNORMAL 4 0.0006
623 TRANSFUSION 6 0.0006
624 SERUM FERRITIN INCREASED 3 0.0006
625 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
626 ILEUS 7 0.0006
627 RHABDOMYOLYSIS 23 0.0006
628 LUNG DISORDER 27 0.0006
629 HYDROCEPHALUS 3 0.0006
630 ARRHYTHMIA 26 0.0005
631 STEVENS-JOHNSON SYNDROME 12 0.0005
632 ARTERIOSCLEROSIS 5 0.0005
633 DYSPNOEA EXERTIONAL 20 0.0005
634 CEREBRAL HAEMORRHAGE 19 0.0005
635 AUTOIMMUNE THYROIDITIS 2 0.0005
636 DERMATITIS CONTACT 6 0.0005
637 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
638 HYPERTONIA 3 0.0005
639 HYPERVENTILATION 3 0.0005
640 HAEMORRHAGIC STROKE 4 0.0005
641 PERIPHERAL COLDNESS 7 0.0005
642 CYANOSIS 8 0.0005
643 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
644 CHOLECYSTITIS 6 0.0005
645 HYPOTONIA 5 0.0005
646 AZOTAEMIA 2 0.0005
647 EXPOSURE DURING PREGNANCY 31 0.0005
648 HEPATITIS B 3 0.0005
649 LEUKOCYTOSIS 9 0.0005
650 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
651 CEREBRAL INFARCTION 12 0.0005
652 SUBARACHNOID HAEMORRHAGE 5 0.0005
653 BRONCHOSPASM 7 0.0005
654 ESCHERICHIA INFECTION 4 0.0005
655 EOSINOPHIL COUNT INCREASED 4 0.0005
656 PNEUMONITIS 13 0.0005
657 MULTIPLE INJURIES 3 0.0005
658 HYPOGLYCAEMIA 23 0.0005
659 SUDDEN DEATH 5 0.0005
660 HYPERTENSION 100 0.0005
661 POST PROCEDURAL COMPLICATION 9 0.0005
662 SEROTONIN SYNDROME 9 0.0005
663 RESPIRATORY DISORDER 14 0.0005
664 ANAPHYLACTIC SHOCK 12 0.0005
665 HIATUS HERNIA 6 0.0005
666 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
667 ANGINA UNSTABLE 3 0.0005
668 PAIN IN JAW 13 0.0005
669 DIVERTICULUM INTESTINAL 2 0.0005
670 HYPOGAMMAGLOBULINAEMIA 3 0.0005
671 DYSPHEMIA 2 0.0005
672 WHEEZING 27 0.0005
673 DISEASE PROGRESSION 53 0.0004
674 BREAST MASS 3 0.0004
675 INTESTINAL PERFORATION 5 0.0004
676 BLOOD CALCIUM DECREASED 5 0.0004
677 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
678 INFARCTION 3 0.0004
679 LYMPHOEDEMA 3 0.0004
680 HYPOKALAEMIA 20 0.0004
681 HYPERTRANSAMINASAEMIA 3 0.0004
682 HYPOMAGNESAEMIA 6 0.0004
683 AGRANULOCYTOSIS 8 0.0004
684 ELECTROLYTE IMBALANCE 5 0.0004
685 FLANK PAIN 4 0.0004
686 DEVICE OCCLUSION 6 0.0004
687 DYSPNOEA 241 0.0004
688 ASTHMA 48 0.0004
689 STAPHYLOCOCCAL INFECTION 14 0.0004
690 LEUKAEMIA 4 0.0004
691 COVID-19 PNEUMONIA 5 0.0004
692 HEPATOCELLULAR INJURY 6 0.0004
693 HYPOCALCAEMIA 8 0.0004
694 PLATELET COUNT DECREASED 45 0.0004
695 NEUTROPENIC SEPSIS 3 0.0004
696 GRAFT VERSUS HOST DISEASE 3 0.0004
697 PANIC REACTION 3 0.0004
698 PRODUCT PRESCRIBING ISSUE 9 0.0004
699 PRESYNCOPE 10 0.0004
700 MOUTH HAEMORRHAGE 3 0.0004
701 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
702 RASH MACULO-PAPULAR 9 0.0004
703 HYDRONEPHROSIS 3 0.0004
704 AMENORRHOEA 7 0.0004
705 INJURY 28 0.0004
706 EMPHYSEMA 4 0.0004
707 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
708 CHRONIC KIDNEY DISEASE 30 0.0004
709 AORTIC ANEURYSM 3 0.0004
710 DYSLIPIDAEMIA 2 0.0004
711 HYPERTHERMIA 3 0.0004
712 ISCHAEMIC STROKE 7 0.0004
713 AMMONIA INCREASED 2 0.0004
714 PROCEDURAL COMPLICATION 3 0.0004
715 SKIN DISORDER 13 0.0004
716 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
717 NAUSEA 308 0.0004
718 PERITONITIS 8 0.0004
719 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
720 BLOOD ALBUMIN DECREASED 3 0.0004
721 HYPOTHYROIDISM 12 0.0004
722 BLOOD BILIRUBIN INCREASED 10 0.0004
723 BEHAVIOUR DISORDER 2 0.0004
724 RENAL DISORDER 17 0.0004
725 EMBOLISM 3 0.0004
726 GASTROINTESTINAL DISORDER 32 0.0004
727 PNEUMONIA 114 0.0004
728 HAEMATURIA 12 0.0004
729 CARDIAC VALVE DISEASE 2 0.0003
730 CARDIAC OPERATION 3 0.0003
731 ANGINA PECTORIS 10 0.0003
732 HAEMATOMA 9 0.0003
733 CARDIAC MURMUR 3 0.0003
734 PYELONEPHRITIS 3 0.0003
735 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
736 RESPIRATORY RATE INCREASED 3 0.0003
737 HAEMOLYTIC ANAEMIA 3 0.0003
738 JAUNDICE 9 0.0003
739 PYREXIA 114 0.0003
740 SEIZURE 38 0.0003
741 EXOSTOSIS 3 0.0003
742 RESPIRATORY ARREST 9 0.0003
743 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
744 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
745 BACK PAIN 74 0.0003
746 UNEVALUABLE EVENT 24 0.0003
747 DELIRIUM 11 0.0003
748 HAEMATEMESIS 8 0.0003
749 DISEASE RECURRENCE 15 0.0003
750 MYDRIASIS 4 0.0003
751 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
752 UNRESPONSIVE TO STIMULI 8 0.0003
753 BLOOD POTASSIUM INCREASED 5 0.0003
754 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
755 TREMOR 51 0.0003
756 HEPATOMEGALY 3 0.0003
757 BODY TEMPERATURE DECREASED 3 0.0003
758 ASPERGILLUS INFECTION 2 0.0003
759 NECK PAIN 17 0.0003
760 SALIVARY HYPERSECRETION 3 0.0003
761 BRAIN INJURY 3 0.0003
762 CHOLECYSTITIS CHRONIC 2 0.0003
763 TOXIC SKIN ERUPTION 3 0.0003
764 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
765 HEMIPARESIS 5 0.0003
766 FLUID RETENTION 15 0.0003
767 NEUTROPHIL COUNT INCREASED 3 0.0003
768 ECCHYMOSIS 2 0.0003
769 RIB FRACTURE 6 0.0003
770 DEATH 250 0.0003
771 SYNCOPE 29 0.0003
772 DRUG-INDUCED LIVER INJURY 9 0.0003
773 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
774 MATERNAL EXPOSURE DURING PREGNANCY 25 0.0003
775 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
776 DECREASED ACTIVITY 3 0.0003
777 TOOTHACHE 5 0.0003
778 MELAENA 6 0.0003
779 AGITATION 20 0.0003
780 CHEST PAIN 50 0.0003
781 IMMUNODEFICIENCY 4 0.0003
782 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
783 CHROMATURIA 6 0.0003
784 DYSARTHRIA 10 0.0003
785 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
786 GASTRIC ULCER 5 0.0003
787 HAEMOGLOBIN DECREASED 27 0.0003
788 DRUG DISPENSING ERROR 4 0.0003
789 VASCULITIS 3 0.0003
790 CARDIAC DISORDER 24 0.0003
791 THERAPY PARTIAL RESPONDER 4 0.0003
792 HEART RATE DECREASED 9 0.0003
793 SPINAL PAIN 3 0.0003
794 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
795 NEUTROPENIA 34 0.0002
796 LOSS OF CONSCIOUSNESS 32 0.0002
797 HEPATITIS C 3 0.0002
798 INTERSTITIAL LUNG DISEASE 12 0.0002
799 PRODUCT USE ISSUE 46 0.0002
800 HYPOPHAGIA 6 0.0002
801 PANCYTOPENIA 13 0.0002
802 HAEMORRHAGE 24 0.0002
803 MUCOSAL INFLAMMATION 6 0.0002
804 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
805 OVERDOSE 49 0.0002
806 DEVELOPMENTAL DELAY 2 0.0002
807 HEART RATE IRREGULAR 5 0.0002
808 PALLOR 6 0.0002
809 MUSCLE SPASMS 40 0.0002
810 HEPATIC STEATOSIS 4 0.0002
811 MASS 3 0.0002
812 ABORTION INDUCED 2 0.0002
813 DIALYSIS 3 0.0002
814 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
815 GLAUCOMA 4 0.0002
816 LOCALISED INFECTION 5 0.0002
817 DIZZINESS POSTURAL 2 0.0002
818 DYSTONIA 4 0.0002
819 GASTROENTERITIS 3 0.0002
820 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
821 EPISTAXIS 15 0.0002
822 ANAPHYLACTIC REACTION 11 0.0002
823 ECONOMIC PROBLEM 3 0.0002
824 MEDICATION ERROR 11 0.0002
825 OSTEOPENIA 3 0.0002
826 BONE MARROW FAILURE 4 0.0002
827 DRY THROAT 2 0.0002
828 EPILEPSY 6 0.0002
829 SKIN DISCOLOURATION 9 0.0002
830 PRODUCT PREPARATION ERROR 4 0.0002
831 TREATMENT FAILURE 16 0.0002
832 LUNG INFECTION 3 0.0002
833 BASAL CELL CARCINOMA 3 0.0002
834 HEART RATE INCREASED 19 0.0002
835 CHEST DISCOMFORT 19 0.0002
836 THROAT TIGHTNESS 5 0.0002
837 DEEP VEIN THROMBOSIS 12 0.0002
838 TREATMENT NONCOMPLIANCE 10 0.0002
839 DENTAL CARIES 2 0.0002
840 CELLULITIS 9 0.0002
841 PERICARDITIS 3 0.0002
842 PANCREATITIS ACUTE 4 0.0002
843 ASTHENIA 66 0.0002
844 RASH MACULAR 6 0.0002
845 CEREBROVASCULAR ACCIDENT 29 0.0002
846 THIRST 3 0.0002
847 BLOOD POTASSIUM DECREASED 5 0.0002
848 EMOTIONAL DISTRESS 20 0.0002
849 RESTLESSNESS 6 0.0002
850 CYTOPENIA 2 0.0002
851 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
852 MYOCARDIAL INFARCTION 28 0.0002
853 COUGH 45 0.0002
854 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
855 INFLAMMATION 8 0.0002
856 CHOKING 3 0.0002
857 FUNGAL INFECTION 5 0.0001
858 DEHYDRATION 20 0.0001
859 DRUG TOXICITY 2 0.0001
860 DERMATITIS 3 0.0001
861 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
862 RED BLOOD CELL COUNT DECREASED 4 0.0001
863 ANXIETY 39 0.0001
864 NEUROPATHY PERIPHERAL 13 0.0001
865 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
866 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
867 PRODUCT DOSE OMISSION ISSUE 39 0.0001
868 HYPERHIDROSIS 17 0.0001
869 URTICARIA 22 0.0001
870 SKIN EXFOLIATION 11 0.0001
871 DRUG ADMINISTRATION ERROR 4 0.0001
872 ANKLE FRACTURE 2 0.0001
873 HEADACHE 81 0.0001
874 FLUSHING 13 0.0001
875 CHOLELITHIASIS 4 0.0001
876 OSTEONECROSIS OF JAW 3 0.0001
877 PALPITATIONS 14 0.0001
878 PAIN 72 0.0001
879 VAGINAL HAEMORRHAGE 5 0.0001
880 MENTAL DISORDER 5 0.0001
881 COLD SWEAT 2 0.0001
882 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
883 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
884 INFECTION 16 0.0001
885 BONE DISORDER 2 0.0001
886 ACCIDENTAL OVERDOSE 4 0.0001
887 DIVERTICULITIS 3 0.0001
888 FEBRILE NEUTROPENIA 7 0.0001
889 COLITIS 4 0.0001
890 MALAISE 46 0.0001
891 LETHARGY 6 0.0001
892 DRUG PRESCRIBING ERROR 2 0.0001
893 PERIPHERAL SWELLING 16 0.0001
894 HEPATIC ENZYME INCREASED 7 0.0001
895 PSYCHOTIC DISORDER 3 0.0001
896 DISABILITY 2 0.0001
897 DISORIENTATION 4 0.0001
898 MYALGIA 17 0.0001
899 CYTOKINE RELEASE SYNDROME 2 0.0001
900 CONFUSIONAL STATE 16 0.0001
901 DYSKINESIA 4 0.0001
902 DISCOMFORT 6 0.0001
903 FEELING HOT 6 0.0001
904 THERAPY CESSATION 5 0.0001
905 OSTEOARTHRITIS 4 0.0001
906 WEIGHT INCREASED 21 0.0001
907 HALLUCINATION 7 0.0001
908 RASH 40 0.0001
909 BLOOD PRESSURE INCREASED 14 0.0001
910 IMPAIRED HEALING 3 0.0001
911 COVID-19 16 0.0001
912 HAEMATOCHEZIA 5 0.0001
913 INFUSION RELATED REACTION 6 0.0001
914 VISUAL ACUITY REDUCED 3 0.0001
915 THROAT IRRITATION 4 0.0001
916 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
917 INCORRECT DOSE ADMINISTERED 20 0.0001
918 CONVULSION 5 0.0001
919 COGNITIVE DISORDER 4 0.0001
920 LYMPHADENOPATHY 3 0.0001
921 CATARACT 5 0.0001
922 DEPRESSION 19 0.0001
923 DIABETIC KETOACIDOSIS 2 0.0001
924 THERAPEUTIC RESPONSE DECREASED 5 0.0001
925 DIARRHOEA 53 0.0001
926 ABDOMINAL PAIN LOWER 2 0.0001
927 FATIGUE 61 0.0001
928 DIZZINESS 39 0.0001
929 DIPLOPIA 2 0.0001
930 MUSCULOSKELETAL PAIN 4 0.0001
931 SPEECH DISORDER 4 0.0001
932 URINARY TRACT INFECTION 13 0.0001
933 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
934 HYPERSENSITIVITY 13 0.0001
935 RECTAL HAEMORRHAGE 3 0.0001
936 DECREASED APPETITE 16 0.0001
937 CHILLS 8 0.0001
938 SURGERY 4 0.0001
939 ABDOMINAL PAIN UPPER 14 0.0001
940 BRONCHITIS 5 0.0001
941 NEPHROLITHIASIS 3 0.0001
942 TINNITUS 3 0.0001
943 PAIN IN EXTREMITY 19 0.0001
944 PRODUCTIVE COUGH 3 0.0001
945 RASH ERYTHEMATOUS 3 0.0001
946 ERYTHEMA 12 0.0001
947 NERVOUSNESS 3 0.0001
948 DRUG EFFECT DECREASED 3 0.0001
949 RASH PRURITIC 3 0.0001
950 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
951 FALL 18 0.0001
952 ARTHROPATHY 3 0.0001
953 DYSPHAGIA 5 0.0001
954 NASAL CONGESTION 3 0.0001
955 WEIGHT DECREASED 14 0.0001
956 NO ADVERSE EVENT 9 0.0000
957 BLINDNESS 2 0.0000
958 DRUG ABUSE 4 0.0000
959 COMPLETED SUICIDE 4 0.0000
960 AMNESIA 3 0.0000
961 SWELLING FACE 3 0.0000
962 DEVICE DISLOCATION 2 0.0000
963 DEVICE ISSUE 4 0.0000
964 PRURITUS 17 0.0000
965 BURNING SENSATION 3 0.0000
966 UNDERDOSE 3 0.0000
967 DRY EYE 2 0.0000
968 ARTHRALGIA 16 0.0000
969 ECZEMA 2 0.0000
970 PROSTATE CANCER 3 0.0000
971 VISION BLURRED 5 0.0000
972 INFLUENZA 4 0.0000
973 MUSCULAR WEAKNESS 4 0.0000
974 BALANCE DISORDER 3 0.0000
975 BONE PAIN 2 0.0000
976 BLADDER CANCER 2 0.0000
977 ADVERSE DRUG REACTION 3 0.0000
978 JOINT SWELLING 4 0.0000
979 OROPHARYNGEAL PAIN 3 0.0000
980 INJECTION SITE ERYTHEMA 4 0.0000
981 BLOOD GLUCOSE INCREASED 6 0.0000
982 DYSPEPSIA 3 0.0000
983 ABDOMINAL DISCOMFORT 5 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
985 PRODUCT QUALITY ISSUE 4 0.0000
986 DEVICE MALFUNCTION 2 0.0000
987 FEELING ABNORMAL 6 0.0000
988 DRUG DEPENDENCE 4 0.0000
989 DRUG WITHDRAWAL SYNDROME 2 0.0000
990 CONTUSION 2 0.0000
991 HYPOAESTHESIA 3 0.0000
992 PARAESTHESIA 3 0.0000
993 INSOMNIA 5 0.0000
994 ALOPECIA 2 0.0000
995 INJECTION SITE PAIN 3 0.0000